An international seminar on the medical industry was held on April 3rd as a sub-forum of the 2019 Guangzhou Annual Investment Conference, during which Sino-Inno Research and KPMG jointly launched their ranking project to select the top 50 bio-tech companies in the Guangdong-Hong Kong-Macao Greater Bay Area.

According to Luo Jianying, representative from KPMG, the project will last from April to September. “We will adopt a big data evaluation system and invite a panel of experts. The evaluation will emphasize the companies’ innovative abilities and examine three major dimensions, technology, market and capital. The ranking will be unveiled by the end of September,”she said.

In addition, the ranking will be open to companies in the fields of medical equipment, bio-medicine&technology and medical services, and involve not only leading companies but also companies with great potential.

This is the second year for Sino-Inno Research and KPMG to organize such project. In 2018, most bio-tech companies in the top 50 are based in the major cities of the Greater Bay Area, such as Guangzhou (27), Shenzhen (13) and Hong Kong (5). 46 percent of the top 50 are medical instrument companies while 36 percent are in the bio-pharmaceutical industry.

Luo Jianying said the Greater Bay Area is now facing great opportunities, especially in the medical industry. “We saw a series of advantageous policies have been pushed forward while more capital, talent and entrepreneurs are flowing to this area,” she said, “with this project, we aim to develop a wind vane of the Bay Area’s medical industry.”

The sub-forum is also supported by Guangdong Medical Valley, an investment incubator platform specializing in medical instrument and bio-pharmaceutical industry,and it attracted more than 100 participants from government departments, academia, bio-tech companies and investment institutions.

Reported by Jasmine Yin

Edited by Wing Zhang